Alzheimer Disease Gene Review Project

SCOPING BIOLOGY_DOMAIN

Species: human

Genes: APP, PSEN1, PSEN2, APOE, TREM2, SORL1, ABCA7, ADAM10, BACE1, NCSTN, APH1A, APH1B, PSENEN, CLU, BIN1, PICALM, CD33, CR1, CD2AP, INPP5D, PLCG2, ABI3, SPI1, MS4A4A, MS4A6A, EPHA1, FERMT2, CASS4, MAPT, GSK3B, CDK5, CDK5R1, LRP1, ABCA1

Alzheimer Disease Gene Review Project

Overview

This project reviews human GO annotations for genes central to Alzheimer disease
genetics and biology. The scope combines Mendelian/familial Alzheimer disease
genes, high-confidence common and rare variant risk genes, and pathway genes
needed to curate reusable disease-relevant modules.

The initial project focus is human Alzheimer disease (MONDO:0004975) with
module curation in the root-level modules/ directory.

Model Species

Primary: Homo sapiens (human)

Genes for Review

Priority 1: Foundational Alzheimer Genetics

Gene Rationale
APP Amyloid precursor protein; central substrate for amyloid beta production
PSEN1 Familial Alzheimer disease presenilin; gamma-secretase catalytic subunit
PSEN2 Familial Alzheimer disease presenilin; gamma-secretase catalytic subunit
APOE Major late-onset Alzheimer disease risk locus; lipid transport and amyloid clearance
TREM2 Rare-variant microglial risk gene; innate immune signaling
SORL1 Endosomal APP trafficking and amyloid processing risk gene
ABCA7 Lipid transport/phagocytosis risk gene
ADAM10 Alpha-secretase in non-amyloidogenic APP processing

Priority 2: Amyloid Processing and Tau Biology

Gene Module context
BACE1 Beta-secretase initiating amyloidogenic APP processing
NCSTN Gamma-secretase complex maturation and substrate recognition
APH1A Gamma-secretase complex subunit
APH1B Gamma-secretase complex subunit; AD-associated target signal in Open Targets
PSENEN Gamma-secretase complex stabilizing subunit
MAPT Tau pathology axis; microtubule-associated tau
GSK3B Tau phosphorylation and kinase signaling context
CDK5 Neuronal kinase implicated in tau phosphorylation biology
CDK5R1 CDK5 regulatory subunit; neuronal kinase activation context

Priority 3: Lipid, Endocytosis, Complement, and Microglial Risk Network

Gene Module context
CLU Apolipoprotein/chaperone risk gene; amyloid handling and complement context
BIN1 Endocytosis and membrane remodeling risk gene
PICALM Clathrin-mediated endocytosis and APP/ApoE trafficking risk gene
CD33 Microglial immune receptor risk gene
CR1 Complement receptor risk gene
CD2AP Endocytosis/cytoskeletal adaptor risk gene
INPP5D SHIP1; microglial phosphoinositide signaling risk gene
PLCG2 Rare coding variant microglial signaling risk gene
ABI3 Rare coding variant microglial cytoskeletal/immune risk gene
SPI1 PU.1 transcription factor; myeloid/microglial regulatory risk locus
MS4A4A MS4A locus representative; microglial/lipid biomarker genetics
MS4A6A MS4A locus representative; Alzheimer disease GWAS signal
EPHA1 Endocytosis/immune signaling risk gene
FERMT2 Integrin/cytoskeletal adaptor risk gene
CASS4 Cytoskeletal adaptor risk gene
LRP1 ApoE receptor and APP/amyloid clearance pathway component
ABCA1 ApoE lipidation and cholesterol efflux pathway component

Pathway Modules

Curate disease-relevant pathway and complex models as ModuleReview YAML files
under modules/:

Module Scope
modules/alzheimer_disease_pathways.yaml Validated overview module with parts for APP processing/amyloid-beta handling, lipid/lipoprotein transport, microglial lipid-debris sensing, tau/cytoskeletal kinase biology, and endocytic/adhesion adaptor systems

Rendered module page: pages/modules/alzheimer_disease_pathways.html.

Validate each module with:

uv run linkml-validate -s src/ai_gene_review/schema/gene_review.yaml -C ModuleReview modules/<module>.yaml

Source Anchors


STATUS

NOTES

2026-06-19

2026-06-20